Unknown biological targets

The term 'Unknown biological targets' refers to a classification in pharmacology where a drug or chemical compound exhibits a clear therapeutic or biological effect, but the specific molecular entity it interacts with—such as a receptor, enzyme, or ion channel—has not been identified (PMC2946714). This scenario is particularly prevalent in phenotypic drug discovery (PDD), where compounds are selected based on their ability to modulate a disease-relevant phenotype in a cell or organism without prior knowledge of the target (ResearchGate: Phenotypic drug discovery). Historically, many widely used drugs, including lithium, metformin, and acamprosate, were utilized for years or decades before their primary molecular targets were elucidated or remain poorly defined (Wikipedia: Drugs with unknown mechanisms of action). Identifying these unknown targets, a process known as target deconvolution, is a major focus of modern chemical biology and is essential for optimizing drug potency, ensuring safety, and understanding the full scope of a drug's polypharmacology (CureFFI: Not every drug has its target). While drugs with unknown targets can be highly effective, they present significant challenges in predicting off-target effects and developing precise biomarkers for patient selection (CD ComputaBio: Drug Off-Target Effect Prediction). Target deconvolution techniques, including chemical proteomics, genetic screening, and computational modeling, are typically employed to transition from an unknown target to a defined molecular mechanism (ResearchGate: Phenotypic drug discovery). Understanding the target is essential for modern drug development to ensure safety and efficacy through rational design and to meet the stringent requirements of regulatory agencies like the FDA (PMC2946714). Consequently, 'Unknown biological targets' represents a temporary classification or a gap in scientific knowledge rather than a specific biological structure.

Other names

Unidentified targetOrphan targetUnknown mechanism of actionNon-target-based mechanism

The mechanism of action is unknown or has not yet been characterized at the molecular level.